tradmap

TELA Earnings TELA Bio, Inc.

Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated

Annual results

Diluted EPS (annual)
-$17 -$9 $0 2019 2020 2021 2022 2023 2024 2025
EPS
Revenue (annual)
$0 $40M $80M 2017 2018 2019 2020 2021 2022 2023 2024 2025
Revenue
Net income (annual)
-$47M -$23M $0 2017 2018 2019 2020 2021 2022 2023 2024 2025
Net income

Quarterly results

Diluted EPS (quarterly)
-$2 -$1 $0 Q3 '22 Q2 '23 Q1 '24 Q3 '24 Q2 '25 Q1 '26
EPS
Revenue (quarterly)
$0 $10M $21M Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
Revenue
Net income (quarterly)
-$13M -$6M $0 Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
Net income

Reported EPS history

1–24 of 24
Q2 20262026-06-30-0.412026-08-1110-Q
Q1 20262026-03-31-0.212026-05-1310-Q
FY 20252025-12-31-0.832026-03-2510-K
Q3 20252025-09-30-0.662025-11-1410-Q
Q2 20262025-06-30-0.472026-08-1110-Q
Q1 20262025-03-31-0.252026-05-1310-Q
FY 20252024-12-31-1.332026-03-2510-K
Q3 20252024-09-30-1.162025-11-1410-Q
Q2 20252024-06-30-0.742025-08-1110-Q
Q1 20252024-03-31-0.232025-05-0810-Q
FY 20252023-12-31-2.042026-03-2510-K
Q3 20242023-09-30-1.512024-11-0810-Q
Q2 20242023-06-30-1.082024-08-1310-Q
Q1 20242023-03-31-0.632024-05-1010-Q
FY 20242022-12-31-2.722025-03-2110-K
Q3 20232022-09-30-2.242023-11-1310-Q
Q2 20232022-06-30-1.622023-08-1010-Q
Q1 20232022-03-31-0.752023-05-1110-Q
FY 20232021-12-31-2.302024-03-2210-K
Q3 20222021-09-30-1.712022-11-1010-Q
Q2 20222021-06-30-1.132022-08-1110-Q
Q1 20222021-03-31-0.562022-05-1110-Q
FY 20222020-12-31-2.232023-03-2310-K
FY 20212019-12-31-17.102022-03-2310-K

Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.